Acurx Pharmaceuticals (ACXP) Misses Q2 EPS by 9c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.26), $0.09 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Varonis Systems (VRNS) call put ratio 4.4 calls to 1 put with a focus on July 35, 40 and 45 calls as share price up 6.4%
• Active options: MSFT PLTR META GOOGL SOFI MSTR IREN AMC IBM SMCI HOOD AMD